DekaBank Deutsche Girozentrale decreased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 9.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 85,270 shares of the medical instruments supplier’s stock after selling 9,373 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in DENTSPLY SIRONA were worth $4,639,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Commonwealth Bank of Australia raised its stake in DENTSPLY SIRONA by 19.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares in the last quarter. Acrospire Investment Management LLC acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth about $113,000. Dupont Capital Management Corp acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth about $116,000. Massey Quick Simon & CO. LLC acquired a new stake in DENTSPLY SIRONA in the 3rd quarter worth about $124,000. Finally, Korea Investment CORP raised its stake in DENTSPLY SIRONA by 139.9% in the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after purchasing an additional 1,251 shares in the last quarter. Institutional investors and hedge funds own 94.68% of the company’s stock.

Several analysts have weighed in on the stock. HC Wainwright reiterated a “buy” rating and issued a $68.00 price objective (down previously from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday, August 14th. Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 price objective for the company in a research note on Monday, November 6th. Morgan Stanley restated an “overweight” rating and issued a $69.00 target price (up from $67.00) on shares of DENTSPLY SIRONA in a research report on Friday, October 6th. TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Finally, Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average target price of $67.00.

In related news, insider Mark Thierer purchased 77,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were bought at an average cost of $66.04 per share, with a total value of $5,085,080.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Francis J. Lunger sold 8,900 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, November 13th. The shares were sold at an average price of $65.90, for a total transaction of $586,510.00. The disclosure for this sale can be found here. Insiders own 1.99% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/dekabank-deutsche-girozentrale-has-4-64-million-holdings-in-dentsply-sirona-inc-xray/1715790.html.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at $67.55 on Monday. The stock has a market cap of $15,515.08, a P/E ratio of 26.91, a P/E/G ratio of 2.67 and a beta of 1.27. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21. DENTSPLY SIRONA Inc. has a 1-year low of $52.53 and a 1-year high of $67.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.04. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.66 EPS. research analysts anticipate that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.